know with the other vaccines they have told me the only vaccine i have taken and can is the flu vaccine. pneumonia and all the others i cannot take for sure. i don't know. it is kind of scary for people who have had transplant, you know? you have to take immunosuppressants and you have got to be careful. i have been lucky. just wear our mask and stay away from people. from we go to mary calling new port richey, florida. she says she will take it. good morning. caller: good morning. i will take it but the county says you sign into the computer. when you call in they do not have the information. i'm on a waiting list for my doctor's office and cvs does not know when, they're giving in the parking lots. you have to go on the computer and they do not have a computer available. i will get it. i have four children in the nursing field. host: let's go to linda calling from trenton, michigan and she will get it as well. good morning. linda, are you there? i seem to have lost linda. we go to kenneth calling from buffalo, new york. good morning. caller: good morning. i am 88 years old. i intend t

we want to know about your experience and lands with the covid vaccine -- and plans with the covid vaccine this year. on tuesday, joe biden outlined the challenges the vaccination efforts are facing and steps his administration plans to take. here's what president-elect biden had to say. [video clip] biden: the administration will spare no effort to make sure people get vaccinated. i have laid out three challenges in our first 100 days. that 100em, ensuring million shots have been administered by the end of the first 100 days. congress provides the funding -- if congress provides the funding, we will be able to meet this goal. the five to six times the current pace to one million shots per day. even with that improvement, even if we boost the speed to one million shots today, there will still take months to have a majority of the population vaccinated. directed my team to prepare a much more aggressive effort with more federal involvement and leadership to get things on track. we will find a way to boost the pace of vaccinations, but as dr. fauci and others have stated these past due days,

if they have availability, they can get the vaccine. the data we are seeing and young people in our state is very clear. kids should be in the classroom. there's a safe way to do that. we had a briefing this week. if anybody wants more information, we will let ryan logan and dr. toomey follow-up in regards to that. i expect you will see a lot of kids going back into the classroom, regardless of what the situation is with vaccinating their staff. however, that is front and center on our minds when we moved to the maxed -- next phase and have more availability. we want to get our educators vaccinated along with other people that are on the front lines of the pandemic in many different ways besides our health care folks. grocery store clerks, front facing people, state government and the private sector and other things. we will continue to roll this out as quickly as we can. >> governor, a new contagious strain of covid is here in the state. you have given some information about that. has there been any spread of that? do we have anymore up

vaccine. both because of the requirement of the specific vaccine and the scarcity of the vaccine. e're hoping in the future we get to a point that will be -- that it will be like the flu vaccine, but we're not there yet. this is the limitations we're working with in the city to make sure people are vaccinated. >> mayor breed: the city has made a decision to set up massive sites that require their own logistics. we have city college which we opened with ucsf, the muscone center and the san francisco produce market in the bayview. those are the other two sites that will open. these sites are going to play a huge role in efficiently providing the vaccine to people who live and work in san francisco, but it's a huge logistical undertaking to establish and operate a site like this. tell me about how these sites will work. >> i can talk about that. you know, this site and this planning has been going on for months now. i really have to say that it's been a huge collaboration between city partners, between our health care system and between our community partners to really think about and

benefits of the vaccines outweigh the risks. s are needed in order to ensure _ measures are needed in order to ensure the — measures are needed in order to ensure the best possible benefit risk. _ ensure the best possible benefit risk. and — ensure the best possible benefit risk, and thirdly all studies and data _ risk, and thirdly all studies and data collection that are put in place — data collection that are put in place in — data collection that are put in place in order to ensure its ongoing safety— place in order to ensure its ongoing safety monitoring. what do we know at this— safety monitoring. what do we know at this moment in time of the safety of the _ at this moment in time of the safety of the oxford astrazeneca vaccine? as we _ of the oxford astrazeneca vaccine? as we have — of the oxford astrazeneca vaccine? as we have heard from the professor, the clinical— as we have heard from the professor, the clinical trial submitted provided a good set of safety data and approximately 12,000 participants have already receive

the number of vaccinations. the number of vaccinations being done is going up. what are the government wants to see if there was vaccinations translating into a drop in infection levels, and then a drop in infection levels, and then a drop in hospital admissions, because the pressure is in hospital are still very high. over 37,000 patients in hospital, more than a third of birds taken up by covid patients. so the government trying to give itself that room, that's time to properly set out a road map that it has more certainty that it can keep to. on vaccinations, though, encouraging results from israel, who have vaccinated more people per head of population than anywhere else in the world, and they are beginning to see vaccination levels and infection levels in older age groups started to drop. that is encouraging, we hope it will be repeated here. so some good news from abroad, and we are hopefully expecting proper data after research looking into the efficacy of vaccines on the new variant of covid—19 in the uk. efficacy of vaccines on the new variant of covid-

the vaccinations started in early december, when we got approval for the pfizer vaccine. december, just shy of 950,000 vaccinations had been done. we now know there have been 1.3 million vaccinations. the oxford vaccine has started to be rolled out, so we now have two vaccines that are being given. we have heard concerns in birmingham that they may be running out of stocks, but we have been assured that the oxford vaccine will be delivered in time for vaccination tomorrow. nhs england say this marks the first week of the nhs putting its foot on the accelerator to get people vaccinated. they say there will be some teething problems, but we have to give it time to bed in. the way tojudge we have to give it time to bed in. the way to judge this is to look at how many we are going to vaccinate by the end of this week. i expect that the nhs will get to 2 million by the end of the week. so from 1.3 million at the start of this week to 2 million by the end of next week —— this week. the next week, they are aiming to do another 2 million on top of that. they want to do 2 million d

will be other fair the coronavirus vaccination program in alongside the flu vaccination program because really the people who need a flu jab every year and the same people who are at risk if they catch corona virus and so therefore we could actually use piggyback on one system on the other to achieve an efficient and fairly streamlined service the english health marchand court says he's working on a timetable to vaccinate every adult by the autumn and the other countries of the u.k. are a symbol of shared joy as indeed other countries around the world it but the state of israel plans to vaccinate their adult population by this spring under criticism for not vaccinating the west bank but they are on a much sharper timescale how come is that one country could get up much quicker vaccination program and other countries can't. i gather from speaking to colleagues at the j.c. the either the joint committee on vaccination and immunization that in fact the bottleneck isn't that we're unwilling it isn't that we don't have enough pairs of hands laid on the pumps it's that the bottleneck is in su

nesbitt to share more about the for the vaccine. >> the u.s. nters for disease control and prevention has a three phased approach to vaccination. supply isse one, constrained and the cdc recommends vaccines should be forstered -- administered best reaching critical populations. this is why you will only see a limited number of options across the city overall to receive your vaccine. phase two assumes there is likely sufficient supply to meet demand, thereby permitting and -- expansion beyond initial populations and the use of a broader provider network. during phase three, we shift to open access to the vaccination because supply will be sufficient and the vaccine will likely be available then through private provider sites. note that,tant to with the covid-19 vaccines that have currently been approved for , they haveu.s. highly complex storage, packaging, and use requirements that limit their ability to be used in small, clinical environments such as private practices, as well as to be used certainp clinics in community or residential settings.

, the health department component of the vaccine and then the community component of the vaccine. but over to you for more details. dr. beyrer: i think that is absolutely right. remember that the cdc ultimately, the agency tasked with managing these distribution programs and the funding for them was going to be in the second recovery act, which was long-delayed. we are very encouraged that the new cdc director, dr. rochelle wolinsky, has already made a very explicit point about being honest about these challenges, about taking them on, and she is an outstanding public health leader, so hopefully, there will be resources to do this commensurate with the need and they will be well used. ellen: great. last question. this is for dr. beyrer. tina from science news -- has the cold requirement for the pfizer vaccine been a limiting factor in this rollout? dr. beyrer: it has certainly been a challenging factor in the rollout. you may know that the idea was initially that there were five doses per vial. you have to defrost those and then use them quickly. it turned out there may be six, and

ocean you still got 2 of the 3 biggest vaccine producers in the world are not producing a single card at 19 vaccine at the moment and have no plans to do so that seems insane when we've got this global pandemic of a proportion that we've never seen before we need to see this is kind of a wartime thing unless we get every single factor in working producing vaccines we're not going to get anything like could immunity this year and we're going to stumble on into next year in the year of 2 with many mutations and many vaccines becoming less effective and it will be the people in the poorest countries where oxfam works that will be hit the hardest by myself lost a very close friend tomorrow in africa last week to cover it 19 this is killing people all over the world not just in the u.k. and europe and they will be lucky if they see a vaccine in the next year at least so we really need to go back to the during thought nothing was happening in the just demonstrates how this system of pharmacy school profits i'm relying on a few firms and i don't really blame the firms the firms

vaccination. and is provided on the ucsf public vaccine website. these are the two primary vehicles as far as disseminating information. and i wanted to take a moment to talk about the challenges we are facing and will face together in implementing a wide and mass vaccine program. why is this different than the flu vaccine? and many know this already, but many may not. and the first is vaccine dose management. and the actual drug itself requires more management than any other vaccine. in particular, this careful attention to thawing the vaccine in a time frame where you know you can get it into a number of patients or people before the vaccine is no longer viable. that takes a fair bit of planning and oversight. second is the fact that we are required with good reason to monitor patients for 15 minutes after the vaccine is administered. this is not part of the flu vaccine in any flu vaccine program. that requires a lot of space and more staff and emergency response team that are not part of the typical team and program. and third and perhaps most im

secondly, on the efficacy of vaccines— secondly, on the efficacy of vaccines against— secondly, on theiant, all the lab studies indicate - vaccines against the new variant, all the lab studies indicate they. all the lab studies indicate they work— all the lab studies indicate they work well— all the lab studies indicate they work well against _ all the lab studies indicate they work well against the _ all the lab studies indicate they work well against the uk - all the lab studies indicate they. work well against the uk variant, but the _ work well against the uk variant, but the reat— work well against the uk variant, but the real proof— work well against the uk variant, but the real proof will— work well against the uk variant, but the real proof will be - work well against the uk variant, but the real proof will be from i work well against the uk variant, . but the real proof will be from data from the _ but the real proof will be from data from the reat— but the real proof will be from data from the real world. _ but the real proof will be from data from the real world. what - but

vaccine. both because of the requirement of the specific vaccine and the scarcity of the vaccine. e're hoping in the future we get to a point that will be -- that it will be like the flu vaccine, but we're not there yet. this is the limitations we're working with in the city to make sure people are vaccinated. >> mayor breed: the city has made a decision to set up massive sites that require their own logistics. we have city college which we opened with ucsf, the muscone center and the san francisco produce market in the bayview. those are the other two sites that will open. these sites are going to play a huge role in efficiently providing the vaccine to people who live and work in san francisco, but it's a huge logistical undertaking to establish and operate a site like this. tell me about how these sites will work. >> i can talk about that. you know, this site and this planning has been going on for months now. i really have to say that it's been a huge collaboration between city partners, between our health care system and between our community partners to really think about and

so with the approval of two vaccines in the u.s., ucsf is now very focused on vaccination as supplies become available. i will say that the size and scale of this effort is unlike any we've ever seen. so let me describe briefly how ucsf as one health system is part of the chain to provide vaccines to the people of san francisco. so ucsf is part of what is called a multi-county system. along with other facilities throughout california. as such, the vaccine is allocated to ucsf directly by the california department of public health. and then the deliveries come to ucsf from the vaccine manufacturers directly, based on the allocation of the california department of public health. it is clear that this is a major and complex initiative, and all of us are learning as we go. what is also clear is that we need to increase the rate at which we're able to deliver vaccine to people. and i believe that from the beginning of the time we started vaccinating two and a half weeks ago, that this is already happening. for example, at ucsf, we're now able to vaccinate up to 1100 people per day, and are

vaccine. both because of the requirement of the specific vaccine and the scarcity of the vaccine. e're hoping in the future we get to a point that will be -- that it will be like the flu vaccine, but we're not there yet. this is the limitations we're working with in the city to make sure people are vaccinated. >> mayor breed: the city has made a decision to set up massive sites that require their own logistics. we have city college which we opened with ucsf, the muscone center and the san francisco produce market in the bayview. those are the other two sites that will open. these sites are going to play a huge role in efficiently providing the vaccine to people who live and work in san francisco, but it's a huge logistical undertaking to establish and operate a site like this. tell me about how these sites will work. >> i can talk about that. you know, this site and this planning has been going on for months now. i really have to say that it's been a huge collaboration between city partners, between our health care system and between our community partners to really think about and

— that the production and the delivery of vaccines to the community come i think— of vaccinesvaccinate 20 million people because of the _ vaccinate 20 million people because of the those regiment allows the second _ of the those regiment allows the second is— of the those regiment allows the second is to be delivered three months — second is to be delivered three months later. it is really important because _ months later. it is really important because the flexibility well over the next — because the flexibility well over the next three months enabled the european _ the next three months enabled the european community to use everything the dose _ european community to use everything the dose of— european community to use everything the dose of vaccine to vaccinate one individual _ the dose of vaccine to vaccinate one individual added with this provide a very good _ individual added with this provide a very good coverage and very good level— very good coverage and very good level of— very good coverage and very good level of protection, the efficacy for the — level of protecti

the vaccine works for it so that's great news. it just highlights the importance of wearing your mask, washing your hand physically distancing and avoiding large indoor gatherings because that is where you catch covid and even a more communicable form of covid with these new variants. it is no match for adequate public health safety measures. >> we have a couple of minutes left. we recently spoke with the director of the national institute of health, doctor francis collins. said the principles of faith and science are complementary and the fate of a lot of people have been shaken over the past year so how do you approach this and what do you say to people? >> oh boy. i think that -- this pandemic has taught us many things but i think one thing that it has taught us is that we need to, not only take care of ourselves but take care of each other and we need to realize that the actions, individual actions, can have an impact on very, very large groups of people and so wearing a mask and washing your hands and social distancing is not

, the german developed a vaccine, the german developed a vaccine, the first to be approved here in theway out of the pandemic, as a way to relieve these lockdowns which are crippling so many towns and cities across the continent. so this news is among the worst possible pieces of news that those governments could receive right now. here in germany, all over the country, there are vaccination centres set up, ready to start immunising people, and yet already they don't have enough, so they are desperate for more of this stuff. the moderna vaccine, which as your von der leyen mentioned, has been approved for use in europe, but it has yet to be rolled out in germany. they are hoping to do that next week. really, everyone was looking to the pfizer biontech one as salvation for the time being, so it is causing great consternation among eu member states. h0??? is causing great consternation among eu member states.— is causing great consternation among eu member states. how was it supply ne . otiated, eu member states. how was it supply negotiated. on _ eu member states. how was it supply nego

up the vaccine. tive that has been developing over the last few days, about two issues to do with the vaccination programme. the 12 week wait that has been introduced, but also the changing guidance about what a last resort mix and match of different types of vaccines would be. so, really, we wanted to get clarity on those key issues, to make sure that this programme was as transparent as possible, so people will continue to have public confidence in it. but it does make sense, doesn't it, to give people firstjabs and then delay the second jabs, if by doing that you can vaccinate more people, more quickly? the deputy chief medical officer, jonathan van—tam, he has an analogy where he says if you've got two elderly grandparents, there are two vaccines available, it's better to give both 89% protection than to give one 95% protection, with two quick doses, and the other no protection at all. that makes logical sense, doesn't it? yes, it does, but i also think that you have to understand that people need

and the expansion of vaccination to seniors over 75 and teachers, this is 50 minutes. >> good evening, joining me are major general tim gowen of the national guard and doctor chan the department of health. we began 2021 at a critical moment in the war against covid-19 which continues to pose a serious threat to our state and our nation. while the initial launch of the vaccine distribution, this does offer a glimmer of hope, we still have a long way to go in this fight, distributing and administering vaccines throughout 2021 will be without question the greatest peace time undertaking in american history and it will be a massive all hands on deck ongoing operation involving the federal, state and local government and the private sector. over the last nearly three weeks, we have already successfully allocated deployed and distributed 270,000, 150 doses of vaccines directly into the hands of our front-line vaccinate her's at hospitals, nursing homes and local health departments to begin phase one a of vulnerable population vaccina

1st take it took delivery of 3000000 doses of the sign of vaccine in december around the clock curfew has come into force in lebanon to combat a dramatic surge in corona virus infections on wednesday there were known queues outside food stores as beirut residents talked up the lockdown will be imposed for 11 days and is the country's toughest response to the pandemic so far it comes amid growing criticism that uncoordinated policies helped fuel the spread of the virus voting is underway in uganda's general election long queues formed before polling stations opened at 7 in the morning after 35 years in power president yoweri must 70 seeking a 6th term but is facing a serious challenge from opposition leader bobby why in the run up to the vote has been plagued by violence. social media. but you. lucked out this is one. gentleman. doing. that. we vote in the dock to make sure that uganda skipped in the dark but we were in the dark about uganda in the us the former governor of michigan is facing criminal charges over the water contamination crisis in th

the u.k. but medical chief say russia's vaccine is up to the task. also this hour from dismissal to exceptions we hear from mainstream journalists from one scoffed at least but make the vaccine and making a u. turn and themselves getting russia's jam. plus the christmas period brings no respite for germany which has reported a surge in public cases that the country's chancellor mourning the situation will only get worse. and they weaken the u.s. president faces a 2nd impeachment bit as pro trump riders are charged with domestic terrorism a look at how democrats are deepening the country's divide. watching our 2 international bring your live news update from our studio here in moscow welcome to the program. moscow's health chiefs say the sputnik the code vaccine does protect against the highly contagious new strain that emerged in the u.k. after russia confirmed its 1st case the country is ramping up production of the job millions more doses are set to be released within a month art is a ghost on the reports. new strain has crossed its borders and sne

to take the vaccine. ant partners in this. we are starting the roll—out but there is much more to come. thank you all for your questions. that concludes today's coronavirus briefing. studio: the health secretary, announcing that 2.6 million vaccine doses have been given so far. they have been given to 2.3 million people. some people already getting their second dose of the vaccine. two fifths of those over 80 have had a first dose and the government is on track to vaccinate the top four priority groups by the middle of february. those priority groups, around 15 million people, account for 88% of covid deaths, and he explained that is why they have to be vaccinated as fast as possible, and he said more than 32,000 people are currently in hospital with covid—19. the average number of deaths with covid in the last week, 926 per day, said the health secretary. our health correspondent, nick triggle is here. talking about vaccinations so far, and every time i talk to you the number goes up, 2.6 million doses gi

vaccinate. the current vaccines we have have very specific requirements or storage and handling requirements that really require us to make sure that we're carefully taking care of the doses and we're not wasting any doses. the other vaccines that are coming through are more table at refrigeration copies. and we hope to be able to work with all the primary care folks that are typically vaccinating any way, but they will be able to store and handle the vaccines safety. hopefully we will get to that state soon, and i'm remaining omt mystic. >> i have an interesting question coming in from a viewer, edward. he wants to know because it mutates, we will need a new vaccine annually like the flu. that is a good question, especially with the strain. >> thank you for that question. the variants emerge in that all viruss mutate. coronavirus itself mutates less frequently than flu does. so we are going to need be vigilant about making sure we're monitoring what variants emerge. we are going to need to be vigil

the vaccine themselves. this will continue to be a heavy logistical lift the state of georgia. that team is working diligently. at this time, there is significant underreporting. we will continue our efforts to ensure the data is transparent, up-to-date, accurate, as we will have. we are making steady progress. phone systems are busier than ever. have beenlth staff working tirelessly for months to battle the pandemic. working quickly to scale up appointments and call centers to assist the public in getting vaccinated. ask for your patience as we work hard. our first responders, frontline health care workers, seniors, and staff and residents at long-term care facilities. we have been working aside the department of community health. to shore up resources for long-term care facilities. announce state support of aid for covid-19 testing. we work alongside our private partners like cvs and walgreens to fully vaccinate residents and staff. no one has been hit harder than covid-19. we intend to stay with them in th

>> hope in the f fight against19 covi- a vaccine breakthrough. this week on "firing line." "what is at stake is beyond the imagination," according to pfizer c.e.o. dr. albert boua,in when descrhis company's race to create a vaccine. pfizer announced its covid vaccine is more than 90% effective. >> 90% is a ga-changer. >> other candidates are promising, too. >> ts is something that just is now going in the very, very strong right direction.va thines are effective. >> so, how and when will americans get the vaccine? will enough people take it? and does this mean life ll one day return to normal? pfizer c.e.o. dr. albert bourla, this week on "firing l >> "firing line with margaret hoover" is made possible in part by... and by... by..orate funding is provided >> welcome to "firing line," albert bourla. >> thank you very much, margaret. >> dr. bourla, the question on ever's mind is, when will average americans realistically be able to get the covid-19 vaccin >> i believe, sometime in the next year maybe the third or the second quarter. and the reason why i'm sayin that -- we will

country, while people who want or need the vaccine can't get it. we will fix the problem by encouraging states to allow more people to get vaccinated be on health care workers, and move through those groups as quickly as they think we can. that includes anyone 65 years or older, a population that has accounted for over 80% of the deaths to date, 80% of the deaths to date. we will also be vaccinating front-line workers like educators, first responders, grocery store workers, etc. it won't mean everyone in this group will get vaccinated immediately, as the supply is not where it needs to be, but it will mean that as vaccines become available, they will reach more people that need them, we will reach out and get the vaccine used. the second thing we are going to change, if we are getting more people vaccinated, then we need more vaccination sites. that is what we are about to harness the full resources of the federal government established thousands of community vaccination centers. on my first day in office, i will instruct the federal emergency manag

how does the pfizer buy on tech vaccine work. i've answered this before but the question is posed again and again so i guess it's maybe time to go over the details again 2 of the vaccines that have now been widely approved one developed by biotech and pfizer and one produced by my dear no are what are called a messenger r.n.a. or already a vaccine now the technology behind them has been the focus of a lot of research for decades but but this is the 1st time they've received widespread approval from health care authorities unlike vaccines based on traditional platforms ones that for example used in activated versions of the virus the biotech pfizer vaccine leads to an immune response of the body by delivering information in the form of a special molecule messenger r.n.a. . m.r.i. in a molecule sar are single stranded chains of what are called nucleotides that fulfill a very important function in cells they're kind of the blueprints for making proteins and act as messengers between a cells headquarters in the nucleus and it's protei

. 17,400 of the moderna vaccine. mayor breed says she will continue to follow the state's guidelines to distribute those doses. >> the federal government and the state are distributing the vaccines. in california the state is giving vaccines directly to health care providers, which includes providers like kaiser permanente, dignity, ucsf and sutter cpmc as well as our own department of public health. >> reporter: dr. colefax confirms cases continue to surge, and right now 26% of icu beds are available in the city. >> we are still seeing an increase in cases and hospitalizations. unfortunately, our case rate is higher than it has ever been. >> reporter: and even with this plan dr. colefax said most of the general public will not receive vaccination until later in the year. next week the city college site will open and the other two will follow in the weeks to come. in the newsroom luz pena, abc 7 news. >> thank you. still ahead, the state of play. players and parents are now pleading with the governor to save what's le

you have to inform them they are eligible and get them the vaccine. state officials don't have enough clarity from federal government on how much supply they get in the coming weeks, which makes it hard to plan for future appointments and figure out, should we have a mass vaccination site, and how many people should we alert if we are not sure the supply will be there? host: this is andrew dunn with us this 40 minutes -- 45 minutes. the phone lines, eastern or central united states, (202) 748-8000. northern or pacific -- mountain or pacific regions, (202) 748-8001. it was earlier this week that health and human services secretary alex azar changed how doses will be allocated. [video clip] effective two weeks from now, we are changing how we allocate first doses among the state. in order to make sure doses are being put to use and put to use for the most honorable. we will be advocating -- allocating them -- based on states and based on the size of the 65 and over population in each state. we are giving states two weeks notice of the shift to give them

so alton, i hope you get the vaccine. host: another tweet, wanting to know if folks should continue to wear masks if all of this is over? , while wethe meantime are getting vaccinated, and for the foreseeable future, masks should be the norm. we need to keep wearing them. once we get to the point of what herd immunity," if we can vaccinate 75 to 80 -- 75% , and thee population transmission is soundly reduced, then i think we can take off our masks and begin to -- carefully -- resume normal activity. anticipate that will happen? it all depends on how many people come in and get the vaccine. 70%-80% by theo end of the summer, maybe the next set of holidays, thanksgiving, new year's, christmas, kwanzaa, maybe they can be near-normal in 2021. that is certainly my hope. host: we are about halfway through our segment. we will do this for another half-hour with dr. william purpose --ofessor of preventive medicine and infectious diseases at vanderbilt university. back to the cdc-covid data remind folks of the numbers out there, 21

it is not a lack of vaccines, it is just having the capacity to vaccinate the number of people who want it, which is a good thing that there are health-care workers here who want to be vaccinated. that is why yesterday when we met with metrohealth directors, we felt that the best way to address that was to have a mass vaccine clinic. several of them probably throughout the metro area, not just in atlanta but in a number of areas, and they are working together right now on that. and i suspect we may see it as early as next week. we must ensure we have enough vaccine. we can do 5000 in a clinic. but right now, we are vaccinating. i know that many of the public health districts are having vaccination clinics this weekend after new year's. so that will continue. it isn't that we are not vaccinating. we are. but the priority will be to get the health-care workers, but we will quickly move into the other phase of vaccinating, particularly the 65 and older, which is of great concern to all of us in public health. >> [inaudible] dr. toomey: the allocation of the vaccine that has come in, distri

i vaccine by the start of the school summer— vaccine by the start of the school summer holidays. _ vaccinebooking a break for around — feel confident in booking a break foraround then? _ feel confident in booking a break for around then? 0n— feel confident in booking a break for around then?— feel confident in booking a break for around then? on the summer holida s, for around then? on the summer holidays. l'm _ for around then? on the summer holidays, i'm going _ for around then? on the summer holidays, i'm going to _ for around then? on the summer holidays, i'm going to cornwall. i holidays, i'm going to cornwall. i've said before i think we will have a great british summer but we have a great british summer but we have a great british summer but we have a lot of work to do between now and then but what we can do is see the line of sight to vaccinating everybody by september and anything before that would be a bonus. a5 everybody by september and anything before that would be a bonus. as the foreign secretary said yesterday, we are driving this as fast as we possibly can. on the lifting

when will i get the vaccine? given the patchwork approach that we have taken in this country and state to rolling this out, it is sometimes difficult to answer those specific understandable questions and really figure out who the right sometimes the county is not the right person. i would say, too, earlier one comment before questions. i want to hear from you. i think earlier i did catch a question how do you certify you have a condition to put you into 1c? that was the gist of the question. the response was you have to work with your medical providers. that is one response, one approach and one way to do it. if you think how the different ways people will get the vaccine, it is not always through primary care, not always through someone who has access to your medical records or will have access easily when they show up at your door. those are really important questions to keep asking local health departments and people in charge of the rollout. one thing i should say is that the cvac meetings we it is on are publ

the pfizer vaccine is the one that the pfizer vaccine is the one that has— that the pfizer vaccine isature, it means that once those _ temperature, it means that once those patches arrive they have to be sent to _ those patches arrive they have to be sent to often quite specialist centres _ sent to often quite specialist centres because of the way it has to be handled — centres because of the way it has to be handled before the injection. the astrazeneca one doesn't have that attached _ astrazeneca one doesn't have that attached to it so it's a far simpler vaccine _ attached to it so it's a far simpler vaccine to— attached to it so it's a far simpler vaccine to distribute around the eu in terms _ vaccine to distribute around the eu in terms of— vaccine to distribute around the eu in terms of its storage and transportation. there are benefits to the _ transportation. there are benefits to the astrazeneca vaccine which obviously — to the astrazeneca vaccine which obviously probably come into play in some _ obviously probably come into play in some of— obviously probably come into play i

range of the vaccine. that's the reason why you've seen announcements that actually the vaccines that we're using are still effective. however, given that as a fact now, we have to be concerned looking forward at what the further evolution of this might be. now, i want to make one mention about the monoclonal antibodies, because they are more seriously inhibited in the sense of impacting on their efficacy by this south african strain. that's the reason why there will be attempts to develop even other antibodies that might be able to avert this particular problem. so looking forward, what we plan to do in collaboration with the companies is to develop what we would call alternative or boosts that would use the same platform, but that would incorporate a particular immunogen that would address these particular variants. for that reason we would always want to be a step or two ahead of what might be a problem in the future. i'll stop now and hand it over to andy slavitt. >> thank you, dr. fauci. also, thank yo

what the vaccine roll—out to succeed. . and on the economy, where we have received the biggest economic downturn in europe. we all want the vaccine roll—out to succeed. want the vaccine roll-out to succeed-— want the vaccine roll-out to succeed. �* , ., ., _, succeed. are you worried there could be an interruption _ succeed. are you worried there could be an interruption to _ succeed. are you worried there could be an interruption to vaccine - be an interruption to vaccine supplies? we have heard that pfizer are shutting down production in the belgian plan for a short while. i think there is capacity in the country to get even more vaccines out to people because of people's willingness to do it. it is great to see so many people taking a stance against the french anti—vaccine movement. the government has to supply those vaccines to the front staff delivering it. we had problems at the start with ppe when the government couldn't get it to the right places in the right amounts. we don't want a repeat of that. they have to ge

the developmf covid-19 vaccines. also serves as a senior scientific liaison for the covid-19 prevention network. our second speaker will be dr. monica schoch-spana at the johns hopkins center for security. she also senior scientist of the department of environmental health and engineering at the bloomberg school. during the pandemic, she has worked to translate scholarly research into actionable recommendations for policymakers and practitioners including as cochair of the working group on readying populations for covid-19 vaccine. we will have time for questions following the panelist remarks. the procedure will be as follows. we will take some questions that have been submitted in advance of the briefing and some questions for the zoom check. if you have a question for the briefing, you can enter it in a zoom chat addressed to all panelists. please enter your name, media outlet, and question. we hope to cover as much as possible. and note that participants will be muted during the briefing and it will be recorded.

protection that the vaccine office. well that's also the 1st bit of that after the 2nd question you asked which is well what happens if i've got coded right now and i go and get vaccinated now there are circumstances when we sometimes use vaccines to prevent people getting an infection because in the case of an infection with a very long incubation period sometimes the vaccine can give your immune system a head start and you never then develop the clinical syndrome that's not the case with this new coronavirus the vaccines don't confer protection soon enough to ward off infection so there will inevitably be people turning up for vaccination who have caught this thing and they could be incubating at that time this is not a worry it's not a concern and it won't do people any harm it might not actually help them to fight off the infection but it certainly won't do any harm there will also be people who have in the past had coronavirus and they're getting vaccinated again will that cause a problem again we don't think that's

the sites have the capacity to administer thousands of vaccines per day. they are already booked with appointments throughout the weekend. that is certainly welcome news as we continue working diligently to vaccinate the vaccinators as well as our frontline health care heroes. know, we haveyou issued a new executive order allowing emergency medical to those who are eligible in georgia. have always been able to administer the vaccine, this also clears other types of emergency medical professionals who are also eligible to administer. this important action, growing the number of people who can vaccinate by more than 10,000 takes us to the ultimate goal of growing a number of people who could be vaccinated. i borrowed this phrase from dr. emery over the last few weeks, as he said vaccines do not save lives, vaccinations to. -- vaccinations do. i want to express my deepest thanks on behalf of all georgians, to the doctors, public health officials who have lead by example to receive the vaccine themselves and are in the fight with us now to continue with adminis

the efficacy for the pfizer vaccine from 14 days to the time _ pfizer vaccine from 14 days to the timer the astrazeneca vaccine trials from day 22, after _ astrazeneca vaccine trials from day 22, after the first dose, when you would _ 22, after the first dose, when you would expect the vaccine to have an effect, _ would expect the vaccine to have an effect, to _ would expect the vaccine to have an effect, to the second dose and calculated efficacy of about 73%. an important _ calculated efficacy of about 73%. an important feature of the a z calculated efficacy of about 73%. an important feature of the a 2 trials is the _ important feature of the a 2 trials is the timing of the second dose varied _ is the timing of the second dose varied across populations and in different— varied across populations and in different parts of the world because the trial— different parts of the world because the trial was done in different areas — the trial was done in different areas. the second dose was given at varying _ areas. the second dose was given at varying time — areas. the second dose was give

efficacy of the vaccine. same for moderna. it doesn't mean we won't have one in the future, but this uk variant, no. and the second with antibodyiboy detection, you can still detect the virus. so even if it's the variant. we don't like the variants, but there's nothing disturbing about vaccine efficacy. >> okay. i have a question from colleen, she says my kaiser has not notified me yet. i'm 78, what advice would you give her? >> i'm so sorry, colleen, because i'm not saying it shouldn't be better than this. my parents are 86 and 84 in utah, and they received a notice they will get the vaccine on january 18th, and the site. i'm not saying things can't be better in san francisco county. and i honestly think that all we'll be doing, everyone will be doing over the next week is making these systems work. so i'm sorry to hear that story, and it will get better. and i think it will get better really fast. >> one last question, doctor, what do you think about people with a history of getting the vaccine? >> it's a ra

at the moment. 5 quite a success with the vaccines at the moment-— quite a success with the vaccinesent. 5 million over 70s start receiving invitations _ the moment. 5 million over 70s start receiving invitations for _ the moment. 5 million over 70s start receiving invitations forjabs, - the moment. 5 million over 70s start receiving invitations forjabs, this - receiving invitations forjabs, this is great news. over 70s are expected to begin receiving coronavirus vaccinations as soon next week as the government wraps up the programme. i know some seven—year—olds who have artie had the vaccine so i think it's already been rolled out in some areas of the country but this is more great news on the vaccination programme. it country but this is more great news on the vaccination programme. if he had not been _ on the vaccination programme. if he had not been for _ on the vaccination programme. if he had not been for the _ on the vaccination programme. it us: had not been for the travel on the vaccination programme. it is: had not been for the travel ban on the vaccination programme. it “i

, you don't have to find the covid vaccine, the covid vaccine finds you. this is the south bronx. this is one of the poorest neighborhoods in new york city and state, one of the poorest in the quunited states. the housing project is called the davidson houses. this is public housing for seniors. about 250 people live here. all of them people of color. they were told last week that covid vaccines would be made available by the state in the lobby of this building. people were very excited but others were a little leerily saying maybe i ought to go to my doctor and have my doctor give it to me. they said who knows when your doctor will have it. you're lucky, you can get it in your building. the turnout was great. between 80 and 90% of the residents that live here got the vaccines this last weekend. a lot of them couldn't be reached. it was a great turnout. a mile and a half north of here at a senior center in the bronx they got 150 doses. the same thing, a great atturno, all 150 doses taken. the amount of locations in the state and number of days and hours wil